Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-92,468
Closed -$2.94M 548
2015
Q2
$2.94M Buy
+92,468
New +$3.01M 0.4% 78
2015
Q1
Sell
-69,074
Closed -$2.04M 569
2014
Q4
$2.04M Buy
+69,074
New +$1.98M 0.26% 161
2014
Q2
Sell
-70,337
Closed -$2.14M 572
2014
Q1
$2.14M Buy
70,337
+5,641
+9% +$168K 0.3% 140
2013
Q4
$1.88M Buy
+64,696
New +$1.88M 0.31% 132

Other funds holding PFE

Santa Fe Partners's PFE Position: Q3 2015 in Review

Santa Fe Partners sold out of Pfizer (PFE) in Q3 2015, closing a stake of 92,468 shares — an estimated $2.94M sold.

Santa Fe Partners first reported a position in PFE in Q4 2013 and held it in 4 quarters. The position peaked at $2.94M in Q2 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Santa Fe Partners reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
  • Santa Fe Partners sold 92,468 Pfizer shares in Q3 2015, an estimated $2.94M.
  • Santa Fe Partners first reported a position in Pfizer in Q4 2013 and held it in 4 quarters.
  • Santa Fe Partners's Pfizer position peaked at $2.94M in Q2 2015.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Santa Fe Partners's 13F filing for Q3 2015, filed 12 Nov 2015.